Evidence map›Paper›PMID 33570308›Full record

ArticleNursing open2021

Did we do everything we could have? Nurses' contributions to medicines optimization: A mixed-methods study.

Vera Logan, Sarah Keeley, Kevin Akerman, Elyne De Baetselier, Tinne Dilles, Nia Griffin, Lisa Matthews, Bart Van Rompaey, Sue Jordan

Open access · goldAbstract read
In one paragraph

Article in Nursing open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Public Perceptions and Attitudes on the Image of Nursing in the Wake of COVID-19.International journal of environmental research and public health · 2023
    Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Vera LoganDepartment of Nursing, Swansea University, Swansea, United Kingdom.ORCID 0000-0001-7437-0272
Sarah KeeleyBournemouth University, Poole, United Kingdom.ORCID 0000-0002-8046-765X
Kevin AkermanDepartment of Nursing, Swansea University, Swansea, United Kingdom.
Elyne De BaetselierFaculty of Medicine and Health Sciences, CRIC (Center of Research and Innovation in Care), NuPhaC, University of Antwerp, Antwerpen, Belgium.ORCID 0000-0002-1586-7825
Tinne DillesFaculty of Medicine and Health Sciences, CRIC (Center of Research and Innovation in Care), NuPhaC, University of Antwerp, Antwerpen, Belgium.ORCID 0000-0003-2817-0944
Nia GriffinDepartment of Nursing, Swansea University, Swansea, United Kingdom.
Lisa MatthewsDepartment of Nursing, Swansea University, Swansea, United Kingdom.
Bart Van RompaeyFaculty of Medicine and Health Sciences, CRIC (Center of Research and Innovation in Care), NuPhaC, University of Antwerp, Antwerpen, Belgium.ORCID 0000-0001-7670-0300
Sue JordanDepartment of Nursing, Swansea University, Swansea, United Kingdom.ORCID 0000-0002-5691-2987
Swansea University · GBUniversity of Antwerp · BEBournemouth and Poole College · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo explore UK professionals' interpretations of medicines optimization and expansion of nurses' roles.

designThis mixed-methods study sought professionals' views on nurses' involvement, competency and engagement in monitoring patients for adverse effects of medicines, monitoring adherence, prescribing and patient education.

methodAn online survey and interviews were undertaken with nurses, doctors and pharmacists in Wales and England, May 2018 to July 2019.

resultsIn all, 220 nurses, 17 doctors and 62 pharmacists responded to the online survey, and 24 professionals were interviewed. Nurses were divided over extending their roles, with 123/220 (55.9%) wishing to extend roles in monitoring patients for possible adverse drug reactions (ADRs), 111/220 (50.5%) in adherence monitoring, 121/220 (55.0%) in prescribing and 122/220 (55.4%) in patient education. The best-qualified nurses were the most willing to increase involvement in monitoring patients for ADRs (aOR 13.00, 1.56-108.01). Interviews revealed that both nurses and doctors assumed the other profession was undertaking this monitoring. Respondents agreed that increasing nurses' involvement in medicines optimization would improve patient care, but expressed reservations about nurses' competencies. Collaboration between nurses and doctors was suboptimal (rated 7/10 at best) and between nurses and pharmacists even more so (6/10 at best).

conclusionJuxtaposition of datasets identified problems with medicines optimization: although most respondents agreed that increasing nurses' involvement would positively impact practice, their educational preparation was a barrier. Only ~50% of nurses were willing to expand their roles to fill the hiatus in care identified and ensure that at least one profession was taking responsibility for ADR monitoring. IMPACT: To improve multiprofessional team working and promote patient safety, nurse leaders should ensure patients are monitored for possible ADRs by at least one profession. Initiatives expanding nurses' roles in medicines optimization and prescribing might be best targeted towards the more educated nurses, who have multidisciplinary support.

Indexed as

NursesNurse's RoleEnglandHumansMedication AdherencePharmacistsWales“care gaps”drug-related side effects and adverse reactionsinterdisciplinary communicationknowledgenursespatient safetypharmaceutical care

Identifiers

PMID33570308
PMCPMC7877145
OpenAlexW3093700661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.